Novel Augmentation of DAOIB and Antioxidant for Early Dementia

Clinical trial NCT06467539 · RECRUITING

Trial details

NCT number: NCT06467539
Sponsor: Chang Gung Memorial Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Mild Cognitive Impairment

Start date: 2024-06-19
Primary completion: 2027-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.